Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.

× No keyword cloud information.

12 in total

1. Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin.

Authors: T P Johnston; G S McCaleb; J A Montgomery
Journal: J Med Chem Date: 1975-01 Impact factor: 7.446

2. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.

Authors: L C Panasci; D Green; R Nagourney; P Fox; P S Schein
Journal: Cancer Res Date: 1977-08 Impact factor: 12.701

3. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.

Authors: J L Imbach; J L Montero; A Moruzzi; B Serrou; E Chenu; M Hayat; G Mathe
Journal: Biomedicine Date: 1975-12-20

4. Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.

Authors: A Clarysse; Y Kenis; G Mathe
Journal: Recent Results Cancer Res Date: 1976

5. Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumour.

Authors: G Mathé; O Halle-Pannenko; C Bourut
Journal: Eur J Cancer Date: 1977-10 Impact factor: 9.162

6. Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours.

Authors: G Mathé; B Serrou; M Hayat; F De Vassal; J L Misset; L Schwarzenberg; D Machover; P Ribaud; D Belpomme; C Jasmin; M Musset; J L Montero; J L Imbach
Journal: Biomedicine Date: 1977-11

7. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.

Authors: P S Schein; M G McMenamin; T Anderson
Journal: Cancer Res Date: 1973-09 Impact factor: 12.701

8. Therapy of advanced gastrointestinal cancer with the nitrosoureas.

Authors: C G Moertel
Journal: Cancer Chemother Rep 3 Date: 1973-05

9. Effectiveness of murine leukemia chemotherapy according to the immune state: reconsideration of correlations between chemotherapy, tumour cell killing, and survival time.

Authors: G Mathé; O Halle-Pannenko; C Bourut
Journal: Recent Results Cancer Res Date: 1977

10. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.

Authors: T Anderson; M G McMenamin; P S Schein
Journal: Cancer Res Date: 1975-03 Impact factor: 12.701

5 in total

1. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.

Authors: M Hayat; C Bourut; E Chenu; J L Montero; J L Imbach; J S MacDonald; G Mathé
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

2. The multiplication of analogs, the best strategy for rapid extension of the oncostatic arsenal. How can they be compared experimentally?

Authors: G Mathé; C Jasmin
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.